Overview

Curcumin for Type 2 Diabetic Patients

Status:
Unknown status
Trial end date:
2010-03-01
Target enrollment:
Participant gender:
Summary
There are evidence that there is an association between insulin resistance and prolonged hyperinsulinemia or hyperglycemia in Type 2 diabetic patients. This will trigger oxidative stress system via reactive oxygen species (ROS) and lead to a high level of Nitric oxide. This can contribute to a significant change in blood vessel and could end up with the complications from cardiovascular disease and increased mortality rate of type 2 diabetic patients. The purpose of the present study was to examine the effectiveness of the curcumin in type 2 diabetic patients on the reduction of atherosclerosis events by examining pulse-wave velocity (PWV) and plasma high-sensitivity C-reactive protein (CRP) test and on blood sugar lowering, glycosylated hemoglobin (HBA1c), lipid profile, and insulin resistance.
Phase:
Phase 4
Details
Lead Sponsor:
Srinakharinwirot University
Collaborator:
Ministry of Health, Thailand
Treatments:
Curcumin